Effects of Tax Proposals and Cigarette Availability on Tobacco Purchasing

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorVirginia Polytechnic Institute and State University

About this trial

This study will investigate the effects of normal-nicotine versus low-nicotine cigarette availability in the context of four tax proposals (Tobacco Parity, Nicotine-Content, Harm-Reduction, and Modified Risk Tobacco Product-based taxes) on tobacco product purchasing patterns in a virtual marketplace.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

provide informed consent

provide a breath carbon monoxide sample ≥ 8 ppm,

be at least 21 years of age (the legal age to purchase tobacco),

smoke at least 10 cigarettes daily, and

Disqualifiers

report uncontrolled physical or mental health conditions (e.g., uncontrolled diabetes, high blood pressure, major depressive disorder, etc.),

use of smoking cessation medications (e.g., nicotine replacement, bupropion, varenicline) in the past 30 days,

report concrete, immediate plans to alter/quit using their usual tobacco products in the next 30 days,

be pregnant or lactating, or

Trial design

Design model

Parallel

Treatments tested in this trial

  • Harm Reduction Tax - Normal Nicotine Cigarettes Available

    Behavioral

    In the Harm Reduction Tax Condition, tobacco products in the Experimental Tobacco Marketplace are placed into three tax tiers: high-, medium-, and no-tax. All combustible products with high abuse liability are placed in the high-tax tier. All non-combustible products or combustible products with low abuse liability are placed in the medium-tax tier. Nicotine Replacement Therapy products are placed in the no-tax tier. The participant's preferred normal-nicotine content cigarettes are available in the marketplace. Participants complete two trials with all products offered at market price, and five trials with prices for each product increasing proportionally to tax tier.

  • Harm Reduction Tax - Normal Nicotine Cigarettes Not Available

    Behavioral

    In the Harm Reduction Tax Condition, tobacco products in the Experimental Tobacco Marketplace are placed into three tax tiers: high-, medium-, and no-tax. All combustible products with high abuse liability are placed in the high-tax tier. All non-combustible products or combustible products with low abuse liability are placed in the medium-tax tier. Nicotine Replacement Therapy products are placed in the no-tax tier. The participant's preferred normal-nicotine content cigarettes are NOT available in the marketplace. Participants complete two trials with all products offered at market price, and five trials with prices for each product increasing proportionally to tax tier.

  • Modified Risk Tobacco Product Tax - Normal Nicotine Cigarettes Available

    Behavioral

    In the Modified Risk Tobacco Products tax condition, tobacco products in the Experimental Tobacco Marketplace are placed into three tax tiers: high-, medium-, and no-tax. In this condition, all non-MRTP tobacco products are placed in the high-tax tier, MRTPs are placed in the medium-tax tier, and Nicotine Replacement Therapy products are placed in the no-tax tier. The participant's preferred normal-nicotine content cigarettes are available in the marketplace. Participants complete two trials with all products offered at market price, and five trials with prices for each product increasing proportionally to tax tier.

  • Modified Risk Tobacco Product Tax - Normal Nicotine Cigarettes Not Available

    Behavioral

    In the Modified Risk Tobacco Products tax condition, tobacco products in the Experimental Tobacco Marketplace are placed into three tax tiers: high-, medium-, and no-tax. In this condition, all non-MRTP tobacco products are placed in the high-tax tier, MRTPs are placed in the medium-tax tier, and Nicotine Replacement Therapy products are placed in the no-tax tier. The participant's preferred normal-nicotine content cigarettes are NOT available in the marketplace. Participants complete two trials with all products offered at market price, and five trials with prices for each product increasing proportionally to tax tier.

  • Nicotine Content Tax - Normal Nicotine Cigarettes Available

    Behavioral

    In the Nicotine-Content Tax Condition, products in the Experimental Tobacco Marketplace are placed into three tax tiers: high-, medium-, and no-tax. In this condition, products with greater than 3 mg nicotine per single unit are placed in the high-tax tier, products with 0.6-3.0 mg/unit in the medium-tax tier, and those with 0.5 mg/unit or less in the no-tax tier. The participant's preferred normal-nicotine content cigarettes are available in the marketplace. Participants complete two trials with all products offered at market price, and five trials with prices for each product increasing proportionally to tax tier.

  • Nicotine Content Tax - Normal Nicotine Cigarettes Not Available

    Behavioral

    In the Nicotine-Content Tax Condition, products in the Experimental Tobacco Marketplace are placed into three tax tiers: high-, medium-, and no-tax. In this condition, products with greater than 3 mg nicotine per single unit are placed in the high-tax tier, products with 0.6-3.0 mg/unit in the medium-tax tier, and those with 0.5 mg/unit or less in the no-tax tier. The participant's preferred normal-nicotine content cigarettes are NOT available in the marketplace. Participants complete two trials with all products offered at market price, and five trials with prices for each product increasing proportionally to tax tier.

  • Tobacco Parity Tax - Normal Nicotine Cigarettes Available

    Behavioral

    In the Tobacco Parity Tax condition, tobacco products in the Experimental Tobacco Marketplace are placed into three tax tiers: high-, medium-, and no-tax. In this condition, all tobacco products are placed in the high-tax tier while products that do not contain tobacco (e.g., herbal cigarettes and nicotine-free ENDS) are placed in the medium-tax tier. Nicotine Replacement Therapy products are placed in the no-tax tier. The participant's preferred normal-nicotine content cigarettes are available in the marketplace. Participants complete two trials with all products offered at market price, and five trials with prices for each product increasing proportionally to tax tier.

  • Tobacco Parity Tax - Normal Nicotine Cigarettes Not Available

    Behavioral

    In the Tobacco Parity Tax condition, tobacco products in the Experimental Tobacco Marketplace are placed into three tax tiers: high-, medium-, and no-tax. In this condition, all tobacco products are placed in the high-tax tier while products that do not contain tobacco (e.g., herbal cigarettes and nicotine-free ENDS) are placed in the medium-tax tier. Nicotine Replacement Therapy products are placed in the no-tax tier. The participant's preferred normal-nicotine content cigarettes are NOT available in the marketplace. Participants complete two trials with all products offered at market price, and five trials with prices for each product increasing proportionally to tax tier.

Treatment groups

316 Participants
are divided into 4 treatment groups
Group A: Tobacco ParityExperimental treatment 2 interventions
Group B: Nicotine ContentExperimental treatment 2 interventions
Group C: Harm ReductionExperimental treatment 2 interventions
Group D: Modified Risk Tobacco Products (MRTP)Experimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Percent of Budget Allocated to Products from each Tax Tier

The investigators will measure the percent of each participant's study budget spent on products from each of the three tax tiers (high-, medium, and no-tax).

Time frame
Day 1

Secondary outcomes

1

Quantity of Products Purchased from each Tax Tier

The investigators will measure the quantity of individual units of tobacco/nicotine products purchased from each tax tier (high-, medium, and no-tax).

Time frame
Day 1

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Virginia Polytechnic Institute and State University

Lead sponsor

Roswell Park Comprehensive Cancer Center

Collaborator

National Cancer Institute (NCI)

Collaborator